Introduction
Epilepsy is one of the most common neurologic problems worldwide 1 and characterized by recurrent unprovoked seizures. 2 The relationship between epilepsy and the endocrine system has been investigated by neurologists, endocrinologists, and basic scientists. 3 Some studies have suggested a relationship between epilepsy and GH, sex hormones, the NPY system, nesfatin-1, ghrelin, and chromogranin A. 4 It is also reported that mean daily blood concentrations of ACTH, cortisol and beta-endorphin in patients with epilepsy are higher in comparison with those of the healthy volunteers. 5 Ghrelin is a 28-amino acid motilin-related peptide. The peptide is characterized by the presence of an n-octanoylation on the hydroxy group of serine in position 3. 6 The octanoylated peptide hormone is produced and secreted by A-like cells within the oxyntic glands of the stomach. 7 Ghrelin circulates in the bloodstream in two major forms: acylated (AG; or n-octanoylated) and unacylated (UAG; or desoctanoylated or desacylated). 8 Acylation is a post-transcriptional modification that is essential for binding to the growth hormone secretagogue receptor (GHS-R) to a point that ghrelin is originally supposed to be biologically active only in acylated form. 6 The acyltransferase that catalyzes ghrelin octanoylation has recently been identified as ghrelin O-acyltransferase (GOAT).
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Ghrelin exerts neuroendocrine effects of eliciting growth hormone release, regulating appetite and energy metabolism, and carries many other functions in a variety of tissues and organs such as gastroenteropancreatic, cardiovascular, reproduction, and immune systems. 10 A definite relationship between ghrelin and seizure has also been demonstrated in animals and humans, although the results are controversial. 4 Some research has suggested that serum ghrelin levels are enhanced in patients with epilepsy 11 and in prepubertal epileptic children treated with valproic acid (VPA). 12 On the other hand, some studies have shown that ghrelin levels decreased in epileptic adults 13 and normalweight prepubertal children 14 taking VPA treatment. In addition, Aydin et al. reported that serum and saliva ghrelin levels were lower in epileptic patients before treatment than in controls. 2 To clarify these controversies, evaluation of blood ghrelin levels immediately after induced epileptic seizures in animals is beneficiary. Therefore, the purposes of this study were: (1) to determine AG and UAG levels in blood samples from pentylenetetrazole (PTZ)-induced epileptic rats using an enzyme-linked immunosorbent assay (ELISA); (2) to determine any association between ghrelin and epilepsy and clarify the controversial results reported for this hormone.
Materials and methods

Chemicals and instruments
PTZ was purchased from Tocris Bioscience, UK (Bristol). Blood AG and UAG levels were determined by ELISA using an ELISA reader Aim: Epilepsy is one of the most common neurologic problems worldwide. A relationship between epilepsy and hormones has been demonstrated. This study was designed to investigate the effect of seizure on blood ghrelin level. Methods: Twenty male Wistar rats were divided into two groups. The control group received saline and the pentylenetetrazole (PTZ) group received a single convulsive dose (50 mg/kg) of PTZ. Thirty minutes later blood samples were collected and acylated and unacylated ghrelin levels in the plasma were assayed. Results: Acylated or active form of ghrelin decreased significantly (p < 0.05) after a PTZ-induced seizure, but the reduction of unacylated and total blood ghrelin levels failed to reach statistical significance. Conclusion: These findings may reflect that PTZ-induced epilepsy decreases AG of plasma.
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(Stat Fax, Awarness, USA) and AG and UAG kits (Cat. No. RD 394062400R and Cat. No. RD394063400R, Biovendor co, Czech Republic).
Animals
All experimental procedures were approved by the Regional Ethics Committee of Tabriz University of Medical Sciences. The experiments were performed on male Wistar rats (220-260 g) with food and water available ad libitum, except during the 30 min of procedure. Animals were maintained under controlled temperature (21-23 8C) and light (12 h light, 12 h dark) and with a humidity of 5-10%. All the experimental procedures were carried out between 08.00 and 10.00 a.m.
Experimental design
Twenty rats were divided into two groups: control (n = 10) and PTZ (n = 10). The PTZ group received a single convulsive dose (50 mg/kg) of PTZ and the control group received the same volume of saline, intraperitoneally (i.p.). Seizures were elicited in all PTZreceiving rats. After 30 min of the injections, blood samples were taken from the animals' heart and collected in tubes containing EDTA and p-hydroxymercuribenzoic acid (1 mM in the final sample volume) to prevent the degradation of AG by protease. Samples were immediately centrifuged at 3500 rpm for 10 min at +4 8C and then, the plasma was transferred into separate tubes. Samples were immediately assayed.
Statistical analysis
SPSS 13.0 software was used for statistical comparisons of data, and data expressed as the means AE SEM. Differences in AG, UAG and total ghrelin levels between the groups were analyzed by independent Student's t-test (one-or two-tailed) and p < 0.05 was accepted as significant.
Results
As shown in Fig. 1 , an independent Student's t-test indicated that AG levels of blood decreased significantly (p < 0.05) after i.p. injection of PTZ, compared to saline groups.
Figs. 2 and 3 illustrate the effect of PTZ-induced seizure on UAG and total ghrelin levels of blood, respectively. Independent Student's t-tests indicated that UAG and total ghrelin levels of blood did not change significantly with respect to control group. AG/UAG ratio also was not modified by PTZ-induced seizures.
Discussion
To our knowledge, this is the first study to examine blood ghrelin levels in PTZ-induced seizures in rats. The results of this study showed that active form or acylated blood ghrelin levels decreased significantly after PTZ-induced seizures. UAG and total blood ghrelin levels also decreased although they failed to reach statistical significance. The results for the blood ghrelin response to the PTZ-induced seizure showed that measuring the concentration of ghrelin is a useful method for studying plasma ghrelin changes over short time.
In recent years, many researchers have focused on the relationships between epilepsy and the endocrine system since epileptic seizures are related to the temporary changes in hormone secretion. 2 A definite relationship between ghrelin and seizures has been already demonstrated in animals and humans, although the results are controversial. Some authors have demonstrated that ghrelin levels were increased in children treated with VPA in comparison to healthy controls. 12, 15 Berilgen et al. also reported that serum ghrelin levels were higher in epilepsy patients who received antiepileptic drug therapy than a control group.
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Contradictorily, circulating ghrelin levels were significantly lower in epileptic patients treated with VPA in pubertal 13 and prepubertal periods. 14, 16 Some studies also showed that both acylated and deacylated forms of serum and salivary ghrelin were depressed in epileptic patients before and after specific treatment with respect to normal controls. [ ( ) T D $ F I G ] [ ( ) T D $ F I G ] Our results confirm earlier studies that document that the ghrelin level of blood decreases with epilepsy. In addition our results showed that AG decreased significantly but the reduction of UAG and total levels were not significant. Two possibilities may be considered in this regard: (1) ghrelin is reduced by a feed back system or (2) uptake of AG is increased by CNS structures to modulate epileptic discharges.
In accordance with the first possibility, some hormones can reduce the production, acylation or secretion of ghrelin such as somatostatin and leptin.
Somatostatin, a peptide produced in the brain, gastrointestinal tract, and pancreas, exerts a broad spectrum of biological activities through paracrine, endocrine, and neuroendocrine mechanisms. 17 It is preferentially released from neurons under conditions of elevated activity (i.e. bursting or high frequency neuronal activation), e.g. during seizures. 18 It is also previously reported that a single intravenous injection of somatostatin reduces the systemic plasma concentration of ghrelin in rats 17 and human healthy volunteers. 19 In addition, somatostatin decreases GOAT expression, 20 enzyme which catalyzes acylation of ghrelin. 9 Therefore, it is possible that blood AG reduction is due to somatostatin released from one of its sources during PTZ-induced seizure. Moreover, a faster rebound of UAG level respect to AG (due to inhibitory effect of somatostatin on GOAT expression) may be occurred. Some studies suggest that kindled seizures induce high serum leptin levels in rats. 21, 22 In this context, kindled female rats had leptin levels approximately twice as high as the controls during diestrus phase. 22 On the other hand, ghrelin is negatively regulated by leptin 23 and physiological concentrations of leptin and a moderate hyperleptinemia directly inhibit ghrelin secretion from the isolated perfused rat stomach. 24 Therefore, ghrelin reduction might be due to release of leptin during PTZ-induced seizure. In a discussion of the second possibility, human ghrelin exhibits saturable binding and endocytosis in the RBE4 rat cerebral microvessel endothelial cell line. 25 On the other hand, blood brain barrier mechanisms regulating ghrelin accumulation by brain may be influenced by pathophysiological events. 26 It has also been shown that ghrelin or its agonists can be considered as an antiepileptic agent in rodents. 27, 28 Therefore, reduction of plasma AG after PTZ-induced seizure could be attributed to its uptake by brain to represent an anti-epileptic effect. In this mater, evaluation of brain ghrelin levels immediately after induced epileptic seizures in animals is beneficiary. Finally, proteolysis of AG 29 and degradation into non-UAG metabolites 30 could be occurred during seizures.
In conclusion, the results obtained from our study showed that AG decreased significantly in blood after PTZ-induced seizures. In the future, a better understanding of the mechanisms responsible for seizure-induced alterations in hormone levels of plasma may help to prevent these changes.
